Back to User profile » Dr Barry J Make

Papers published by Dr Barry J Make:


Identifying Individual Medications Affecting Pulmonary Outcomes When Multiple Medications are Present

Li Y, Dai R, Gwon Y, Rennard SI, Make BJ, Foer D, Strand MJ, Austin E, Young KA, Hokanson JE, Pratte KA, Conway R, Kinney GL

Clinical Epidemiology 2022, 14:731-735

Published Date: 1 June 2022

Variation in Demographic and Clinical Characteristics of Patients with COPD Receiving Care in US Primary Care: Data from the Advancing the Patient EXperience (APEX) in COPD Registry

Fox C, Pace W, Brandt E, Carter V, Chang KL, Edwards C, Evans A, Gaona G, Han MK, Kaplan A, Kent R, Kocks JWH, Kruszyk M, Le Lievre Chantal, LiVoti TM, Mahle C, Make B, Ratigan A, Shaikh A, Skolnik N, Stanley B, Yawn BP, Price DB

Pragmatic and Observational Research 2022, 13:17-31

Published Date: 29 April 2022

Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population

Sethi S, Make BJ, Robinson SB, Kumar S, Pollack M, Moretz C, Dreyfus J, Xi A, Powell D, Feigler N

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:593-608

Published Date: 20 March 2022

Using Tools as Designed [Letter]

Han M, Make B, Yawn BP

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:591-592

Published Date: 18 March 2022

Identifying a Heart Rate Recovery Criterion After a 6-Minute Walk Test in COPD

Zhao D, Abbasi A, Casaburi R, Adami A, Tiller NB, Yuan W, Yee C, Jendzjowsky NG, MacDonald DM, Kunisaki KM, Stringer WW, Porszasz J, Make BJ, Bowler RP, Rossiter HB

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2545-2560

Published Date: 4 September 2021

Letter to Editor Regarding the OCEAN Study [Letter]

Yawn BP, Make B, Mannino D, Martinez FJ, Han MK

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2501-2502

Published Date: 2 September 2021

Co-Morbidity Patterns Identified Using Latent Class Analysis of Medications Predict All-Cause Mortality Independent of Other Known Risk Factors: The COPDGene® Study

Li Y, Ragland M, Austin E, Young K, Pratte K, Hokanson JE, Beaty TH, Regan EA, Rennard SI, Wern C, Jacobs MR, Tal-Singer R, Make BJ, Kinney GL

Clinical Epidemiology 2020, 12:1171-1181

Published Date: 27 October 2020

Women manifest more severe COPD symptoms across the life course

DeMeo DL, Ramagopalan S, Kavati A, Vegesna A, Han MK, Yadao A, Wilcox TK, Make BJ

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3021-3029

Published Date: 1 October 2018

Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment?

Leidy NK, Martinez FJ, Malley KG, Mannino DM, Han MLK, Bacci ED, Brown RW, Houfek JF, Labaki WW, Make BJ, Meldrum CA, Quezada W, Rennard S, Thomashow B, Yawn BP

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1901-1912

Published Date: 13 June 2018

Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI)

Hareendran A, Make BJ, Zaiser E, Garcia Gil E

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1633-1645

Published Date: 18 May 2018

The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial

Patel NR, Cunoosamy DM, Fagerås M, Taib Z, Asimus S, Hegelund-Myrbäck T, Lundin S, Pardali K, Kurian N, Ersdal E, Kristensson C, Korsback K, Palmér R, Brown MN, Greenaway S, Siew L, Clarke GW, Rennard SI, Make BJ, Wise RA, Jansson P

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1009-1019

Published Date: 27 March 2018

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials

Eriksson G, Calverley PM, Jenkins CR, Anzueto AR, Make BJ, Lindberg M, Fagerås M, Postma DS

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1457-1468

Published Date: 15 May 2017

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD

Calverley PM, Eriksson G, Jenkins CR, Anzueto AR, Make BJ, Persson A, Fagerås M, Postma DS

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:13-25

Published Date: 19 December 2016

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations

Calverley PM, Postma DS, Anzueto AR, Make BJ, Eriksson G, Peterson S, Jenkins CR

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:381-390

Published Date: 25 February 2016

Evaluation of the psychometric properties of the Nighttime Symptoms of COPD Instrument

Mocarski M, Zaiser E, Trundell D, Make BJ, Hareendran A

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:475-487

Published Date: 6 March 2015

A score to predict short-term risk of COPD exacerbations (SCOPEX)

Make BJ, Eriksson G, Calverley PM, Jenkins CR, Postma DS, Peterson S, Östlund O, Anzueto A

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:201-209

Published Date: 27 January 2015